Table 4.
Taqman validation
| Gene | Ratio of fold change/cyclophilin | Ratio of fold change/cyclophilin |
|---|---|---|
| 4 h | 24 h | |
| ANGPT2 | 15.91±1.83 | 18.73±0.88 |
| CXCR4 | 1.02±1.00 | 10.50±1.95 |
| NID2 | 1.89±0.76 | 9.62±1.64 |
| STC1 | 11.00±11.50 | 60.71±4.93 |
Taqman validation
| Gene | Ratio of fold change/cyclophilin | Ratio of fold change/cyclophilin |
|---|---|---|
| 4 h | 24 h | |
| ANGPT2 | 15.91±1.83 | 18.73±0.88 |
| CXCR4 | 1.02±1.00 | 10.50±1.95 |
| NID2 | 1.89±0.76 | 9.62±1.64 |
| STC1 | 11.00±11.50 | 60.71±4.93 |